FDA Inspection 721800 — Carter BloodCare at Keller

Carter BloodCare at Keller — FEI 3003706080

The FDA completed an inspection of Carter BloodCare at Keller on April 27, 2011 in Keller, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 27, 2011
Fiscal Year
2011
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Keller, TX (United States)